Ciara Kazakis, DO | |
6 Tsienneto Rd, Suite 300, Derry, NH 03038 | |
(603) 216-0400 | |
(603) 216-3800 |
Full Name | Ciara Kazakis |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 8 Years |
Location | 6 Tsienneto Rd, Derry, New Hampshire |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629438379 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Home Health & Hospice Care | Merrimack, NH | Home health agency |
St Joseph Hospital | Nashua, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St. Joseph Hospital Of Nashua Nh | 2062455611 | 191 |
News Archive
Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).
Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.
In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.
President Barack Obama seems to be losing the battle to include in the jobs bill - also known as the "extender" bill - a continuation of federal subsidies for laid-off workers to help pay for health insurance through COBRA, The Associated Press reports. Sens. Bob Casey, D-Pa., and Sherrod Brown, D-Ohio, "who are seeking a vote this coming week, want to attach their nearly $7 billion provision to must-pass legislation that would extend unemployment benefits and make changes in dozens of federal programs.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
› Verified 7 days ago
Entity Name | Southern New Hampshire Internal Medicine Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316026677 PECOS PAC ID: 9133111990 Enrollment ID: O20040401000153 |
News Archive
Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).
Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.
In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.
President Barack Obama seems to be losing the battle to include in the jobs bill - also known as the "extender" bill - a continuation of federal subsidies for laid-off workers to help pay for health insurance through COBRA, The Associated Press reports. Sens. Bob Casey, D-Pa., and Sherrod Brown, D-Ohio, "who are seeking a vote this coming week, want to attach their nearly $7 billion provision to must-pass legislation that would extend unemployment benefits and make changes in dozens of federal programs.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
› Verified 7 days ago
Entity Name | St. Joseph Hospital Of Nashua Nh |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093787384 PECOS PAC ID: 2062455611 Enrollment ID: O20050606000515 |
News Archive
Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).
Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.
In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.
President Barack Obama seems to be losing the battle to include in the jobs bill - also known as the "extender" bill - a continuation of federal subsidies for laid-off workers to help pay for health insurance through COBRA, The Associated Press reports. Sens. Bob Casey, D-Pa., and Sherrod Brown, D-Ohio, "who are seeking a vote this coming week, want to attach their nearly $7 billion provision to must-pass legislation that would extend unemployment benefits and make changes in dozens of federal programs.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
› Verified 7 days ago
Entity Name | Catholic Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265487755 PECOS PAC ID: 6103897129 Enrollment ID: O20060801000310 |
News Archive
Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).
Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.
In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.
President Barack Obama seems to be losing the battle to include in the jobs bill - also known as the "extender" bill - a continuation of federal subsidies for laid-off workers to help pay for health insurance through COBRA, The Associated Press reports. Sens. Bob Casey, D-Pa., and Sherrod Brown, D-Ohio, "who are seeking a vote this coming week, want to attach their nearly $7 billion provision to must-pass legislation that would extend unemployment benefits and make changes in dozens of federal programs.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ciara Kazakis, DO 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Ph: (603) 216-0400 | Ciara Kazakis, DO 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Ph: (603) 216-0400 |
News Archive
Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).
Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.
In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.
President Barack Obama seems to be losing the battle to include in the jobs bill - also known as the "extender" bill - a continuation of federal subsidies for laid-off workers to help pay for health insurance through COBRA, The Associated Press reports. Sens. Bob Casey, D-Pa., and Sherrod Brown, D-Ohio, "who are seeking a vote this coming week, want to attach their nearly $7 billion provision to must-pass legislation that would extend unemployment benefits and make changes in dozens of federal programs.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
› Verified 7 days ago
Dr. Zachary S Spigelman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd Ste 204, Derry, NH 03038 Phone: 603-421-2156 Fax: 603-421-2307 | |
Dr. Paul Michael Macdonald, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 | |
Steven Taylor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Road, Suite 301, Derry, NH 03038 Phone: 603-432-8802 Fax: 603-432-7430 | |
Dr. Knut Roalsvig, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 301, Derry, NH 03038 Phone: 603-432-8802 Fax: 603-432-7430 | |
Dr. Andrea B Schneebaum, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 | |
Dr. Laura Jean Fox, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 | |
Dr. Edmund S Schiavoni Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Road, Suite 300, Derry, NH 03038 Phone: 603-216-0400 Fax: 603-216-3800 |